Cutia Therapeutics Announces Management Changes and Relocation of Hong Kong Office
Reuters
Aug 28
Cutia Therapeutics Announces Management Changes and Relocation of Hong Kong Office
Cutia Therapeutics has announced changes in its management, effective 28 August 2025. Ms. Chan Sze Ting has resigned from her roles as company secretary, authorised representative, and process agent. Mr. Leung has been appointed as the new company secretary. Additionally, the company's principal place of business in Hong Kong has been relocated to 31/F, Tower Two, Times Square, 1 Matheson Street, Causeway Bay, Hong Kong.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cutia Therapeutics published the original content used to generate this news brief on August 28, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.